BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 25972487)

  • 21. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells.
    Haniffa M; Shin A; Bigley V; McGovern N; Teo P; See P; Wasan PS; Wang XN; Malinarich F; Malleret B; Larbi A; Tan P; Zhao H; Poidinger M; Pagan S; Cookson S; Dickinson R; Dimmick I; Jarrett RF; Renia L; Tam J; Song C; Connolly J; Chan JK; Gehring A; Bertoletti A; Collin M; Ginhoux F
    Immunity; 2012 Jul; 37(1):60-73. PubMed ID: 22795876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
    Tüting T; Steitz J; Brück J; Gambotto A; Steinbrink K; DeLeo AB; Robbins P; Knop J; Enk AH
    J Gene Med; 1999; 1(6):400-6. PubMed ID: 10753065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes.
    Fu C; Peng P; Loschko J; Feng L; Pham P; Cui W; Lee KP; Krug AB; Jiang A
    Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23730-23741. PubMed ID: 32879009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells.
    Guillerme JB; Boisgerault N; Roulois D; Ménager J; Combredet C; Tangy F; Fonteneau JF; Gregoire M
    Clin Cancer Res; 2013 Mar; 19(5):1147-58. PubMed ID: 23339127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
    Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
    J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.
    Porgador A; Irvine KR; Iwasaki A; Barber BH; Restifo NP; Germain RN
    J Exp Med; 1998 Sep; 188(6):1075-82. PubMed ID: 9743526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptor 3 in nasal CD103
    Takaki H; Kure S; Oshiumi H; Sakoda Y; Suzuki T; Ainai A; Hasegawa H; Matsumoto M; Seya T
    Mucosal Immunol; 2018 Jan; 11(1):82-96. PubMed ID: 28612840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting interferon-alpha to dendritic cells enhances a CD8
    Graham JP; Authie P; Karolina Palucka A; Zurawski G
    Vaccine; 2017 Aug; 35(35 Pt B):4532-4539. PubMed ID: 28743486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of lactate-lysosome axis in dendritic cells by clotrimazole potentiates antitumor immunity.
    Wang Z; Xu F; Hu J; Zhang H; Cui L; Lu W; He W; Wang X; Li M; Zhang H; Xiong W; Xie C; Liu Y; Zhou P; Liu J; Huang P; Qin XF; Xia X
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of respiratory dendritic cells during Klebsiella pneumonia infection.
    Hackstein H; Kranz S; Lippitsch A; Wachtendorf A; Kershaw O; Gruber AD; Michel G; Lohmeyer J; Bein G; Baal N; Herold S
    Respir Res; 2013 Sep; 14(1):91. PubMed ID: 24044871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal Batf3-dependent dendritic cells are required for optimal antiviral T-cell responses in adult and neonatal mice.
    Sun T; Rojas OL; Li C; Ward LA; Philpott DJ; Gommerman JL
    Mucosal Immunol; 2017 May; 10(3):775-788. PubMed ID: 27600308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanosecond pulsed electric field stimulates CD103
    Qian J; Ding L; Wu Q; Yu X; Li Q; Gu Y; Wang S; Mao J; Liu X; Li B; Pan C; Wang W; Wang Y; Liu J; Qiao Y; Xie H; Chen T; Ge J; Zhou L; Yin S; Zheng S
    Cancer Lett; 2024 Jul; 593():216514. PubMed ID: 38036040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Teleost Skin CD8α+ Dendritic-like Cells, Representing a Potential Common Ancestor for Mammalian Cross-Presenting Dendritic Cells.
    Granja AG; Leal E; Pignatelli J; Castro R; Abós B; Kato G; Fischer U; Tafalla C
    J Immunol; 2015 Aug; 195(4):1825-37. PubMed ID: 26179908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
    Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
    J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells.
    Deauvieau F; Ollion V; Doffin AC; Achard C; Fonteneau JF; Verronese E; Durand I; Ghittoni R; Marvel J; Dezutter-Dambuyant C; Walzer T; Vie H; Perrot I; Goutagny N; Caux C; Valladeau-Guilemond J
    Int J Cancer; 2015 Mar; 136(5):1085-94. PubMed ID: 25046660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8⁺ T cells.
    Liang X; Fu C; Cui W; Ober-Blöbaum JL; Zahner SP; Shrikant PA; Clausen BE; Flavell RA; Mellman I; Jiang A
    J Leukoc Biol; 2014 Jan; 95(1):179-90. PubMed ID: 24023259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells.
    Tanaka Y; Koido S; Ohana M; Liu C; Gong J
    J Immunol; 2005 Feb; 174(3):1274-80. PubMed ID: 15661883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.
    Zhou H; Luo Y; Kaplan CD; Krüger JA; Lee SH; Xiang R; Reisfeld RA
    Blood; 2006 Apr; 107(8):3251-7. PubMed ID: 16368879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma.
    Bellone M; Cantarella D; Castiglioni P; Crosti MC; Ronchetti A; Moro M; Garancini MP; Casorati G; Dellabona P
    J Immunol; 2000 Sep; 165(5):2651-6. PubMed ID: 10946294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
    Cancel JC; Crozat K; Dalod M; Mattiuz R
    Front Immunol; 2019; 10():9. PubMed ID: 30809220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.